dobutamine in dextrose

Generic: dobutamine in dextrose

Labeler: hf acquisition co. llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name dobutamine in dextrose
Generic Name dobutamine in dextrose
Labeler hf acquisition co. llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

dobutamine hydrochloride 100 mg/100mL

Manufacturer
HF Acquisition Co. LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1664
Product ID 51662-1664_47bf8f3f-ee08-c235-e063-6394a90a96fb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020201
Listing Expiration 2027-12-31
Marketing Start 2005-08-12

Pharmacologic Class

Classes
adrenergic beta-agonists [moa] beta-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621664
Hyphenated Format 51662-1664

Supplemental Identifiers

RxCUI
309985
UNII
0WR771DJXV

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name dobutamine in dextrose (source: ndc)
Generic Name dobutamine in dextrose (source: ndc)
Application Number NDA020201 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 100 mg/100mL
source: ndc
Packaging
  • 250 mL in 1 BAG (51662-1664-1)
source: ndc

Packages (1)

Ingredients (1)

dobutamine hydrochloride (100 mg/100mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "47bf8f3f-ee08-c235-e063-6394a90a96fb", "openfda": {"unii": ["0WR771DJXV"], "rxcui": ["309985"], "spl_set_id": ["3418aa46-2d9a-39f3-e063-6294a90a2961"], "manufacturer_name": ["HF Acquisition Co. LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "250 mL in 1 BAG (51662-1664-1)", "package_ndc": "51662-1664-1", "marketing_start_date": "20050812"}], "brand_name": "DOBUTAMINE IN DEXTROSE", "product_id": "51662-1664_47bf8f3f-ee08-c235-e063-6394a90a96fb", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic beta-Agonists [MoA]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "51662-1664", "generic_name": "DOBUTAMINE IN DEXTROSE", "labeler_name": "HF Acquisition Co. LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DOBUTAMINE IN DEXTROSE", "active_ingredients": [{"name": "DOBUTAMINE HYDROCHLORIDE", "strength": "100 mg/100mL"}], "application_number": "NDA020201", "marketing_category": "NDA", "marketing_start_date": "20050812", "listing_expiration_date": "20271231"}